PharMedQuest Makes Strategic Investment in helparound

Enters Agreement to Optimize HIV and Hep-C Patient Experiences for Mobile through ACE™ Program. Enhanced CRM solution will incorporate helparound's mobile patient intelligence platform to support patients with complex diseases.
 
BREA, Calif. - Dec. 13, 2017 - PRLog -- PharMedQuest, a healthcare management company, has made a strategic investment in helparound, and entered an agreement to co-market its patented mobile patient intelligence platform to specialty pharmaceutical companies and patient hubs.

PharMedQuest is working with helparound to enhance its clinical customer relationship management (CRM) solution, ACE™, which focuses on managing patients with complex diseases such as HIV and Hepatitis C. Through the partnership, PharMedQuest will leverage helparound's mobile intelligence platform to enable responsive patient interactions for improving patient compliance and overall outcomes.

Helparound works with patient marketing and support groups to maximize the impact of their patient services through mobile. Its platform applies a combination of deep behavioral insights and predictive data-driven algorithms to continuously learn, adapt and respond to patients' real life daily habits through their smartphones. Through helparound, companies can deliver personalized educational resources, brand messaging and community support based on each patient's personal circumstances and evolving treatment experiences.

By offering educational resources and real-time patient support, in addition to crowd-sourced community support, helparound's platform will provide ACE™ with a mobile channel to engage with its patients, improve access to care and increase retention and adherence.

"We are excited to partner with helparound to match patients who have complex diseases with the appropriate resources and improve their access to care," said Chris Nee, CEO at PharMedQuest. "We think that customized interactions with patients in their real-life environment will lead to cost-effective quality care."

"PharMedQuest is at the forefront of specialty health management," said Yishai Knobel, helparound's co-founder and CEO, "We look forward to working with them on enhancing the power of ACE™ to engage and support patients managing complex diseases every day, in the effort to accelerate access to cost-effective care and better outcomes."

ABOUT HELPAROUND
Helparound delivers mobile patient services to alleviate the daily burden of complex treatments for chronic illnesses, such as diabetes, kidney failure, HIV and more. Its patented AI-powered mobile patient intelligence platform learns, adapts and responds to individual patient behaviors. With helparound, companies generate and collect deep behavioral insights to deliver personalized support through each user's smartphone, including financial resources, education, crowd-sourced community, reminders and chat support.

To learn more about helparound please visit www.helparound.co or call +1 (646) 798-9555

ABOUT PHARMEDQUEST
PharMedQuest, an Inc. 5000 company, delivers the highest cost-effective care to Patients by investing in optimal resources to build transformational & innovative tools, knowledge, and management for Clinicians & Payors.  Our consulting experience allows us to provide the most robust process, comprehensive insight and sustainable value for our clients. PharMedQuest is ACHC accredited with a distinction in Oncology and services include ARC™ medical benefit management, P340B® management, ACE™ patient management and specialty pharmacy services. For more information about PharMedQuest call (714) 364-4008 or visit www.PharMedQuest.com.

Contact
PharMedQuest
***@pharmedquest.com
End
Source: » Follow
Email:***@pharmedquest.com Email Verified
Tags:Specialty, Mobile, Healthcare
Industry:Health
Location:Brea - California - United States
Subject:Partnerships
Account Email Address Verified     Disclaimer     Report Abuse
Page Updated Last on: Dec 13, 2017
PharMedQuest News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share